News: Front Section
Posted: July 3, 2020
Yacobian of Cummings Properties handles 4,600 s/f lease to Minovia
Woburn, MA International life sciences firm Minovia Therapeutics is expanding its U.S. operations from Kendall Sq. in Cambridge to include a 4,600 s/f facility in the local growing technology cluster. The venture-backed company is slated to commence its GMP cell therapy manufacturing at 12 Gill St., a Cummings Properties building, this fall. Senior leasing director Rob Yacobian of Cummings Properties worked with Cushman & Wakefield executive managing director Ted Lyon on the lease.
“The location and existing buildout of the space make it ideal for Minovia’s operations,” said Minovia Therapeutics owner’s representative Ed Dondero.
“A growing number of urban firms are realizing that a thriving science hub and significant cost savings await them along the 128 belt just north of the city,” said Yacobian. “The Gill St. site offers Minovia a convenient, visually appealing setting in an established biotech community that continues to evolve.”
Among the life sciences firms located at 12 Gill St. are ReForm Biologics, Unchained Labs, and Farcast Biosciences. Other new neighbors in the industry include Amgen, Azurity Pharmaceuticals, Covaris, Bio2 Technologies, Genturi, Modular Genetics, and Verdox.
Minovia’s new space will include a mix of office and lab space. The firm is constructing a state-of-the-art pharmaceutical clean room in the suite.
Tags:
Front Section
MORE FROM Front Section
Newmark negotiates sale of 10 Liberty Sq. and 12 Post Office Sq.
Boston, MA Newmark has completed the sale of 10 Liberty Sq. and 12 Post Office Sq. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble,
Quick Hits
.png)
Columns and Thought Leadership
Four tips for a smooth 1031 Exchange - by Bill Lopriore
Many real estate investors do not understand the specific requirements that must be met to secure the benefits of a tax-deferred 1031 exchange. For example, the replacement property must be identified within 45 days of the closing date of the relinquished property.
How COVID-19 has impacted office leasing - by Noble Allen and John Sokul
To say that the effects of COVID-19 has transformed office leasing is an understatement. When COVID-19 was at its peak, office spaces were practically abandoned either through governmental mandates or through actions taken by businesses themselves.
Make PR pop by highlighting unique angles - by Stanley Hurwitz
Coming out of the pandemic, a client with three hotels in Provincetown, Mass., needed ways to let the world know his properties were open for business for the 2021 tourist season.
Five ways to ruin a Section 1031 Like-Kind Exchange - by Bill Lopriore
While there is some flexibility when structuring a like-kind exchange, some important requirements must be met. A mistake can ruin your exchange. Here are five mistakes to avoid:
